VTVT MEXC RealStocks
Own real VTVT shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-12 19:46:00. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
vTv Therapeutics Inc. (VTVT) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $20.77, with a market capitalization of $84.24M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $20.33 to $44.00. This page covers its latest market performance, valuation, price trends and company information.
$84.24M | |
$21.30 | |
$21.46 | |
$20.33 | |
$21.47 | |
3.88K | |
35.35K | |
-- | |
$44.00 | |
$20.33 | |
-- | |
-- |
vTv Therapeutics Inc. (VTVT) is currently trading at $20.77 as of 2026-11-12 19:45:00, down 2.51% ($0.54) from the previous close of $21.47
During today's regular trading session, VTVT has traded between $20.33 and $21.46, with a trading volume of 3.88K shares. The current price is near the middle of today's range.
Over the past seven days, vTv Therapeutics Inc. (VTVT) moved from $23.55 to $20.77, representing a decline of 11.83% ($2.79).
The stock traded between $20.33 and $25.26 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 21.18 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 1.8%
VTVT is currently trading at $20.77, placing it 1.8% of the way from its 52-week low of $20.33 to its 52-week high of $44.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
vTv Therapeutics Inc is a late-stage biopharmaceutical company focused on developing oral, small-molecule drug candidates intended to help treat people living with diabetes and other chronic diseases. Its clinical pipeline is led by cadisegliatin (TTP399), a novel, small-molecule, liver-selective glucokinase activator (GKA) currently being evaluated as a potential oral adjunctive therapy to insulin for the treatment of type 1 diabetes (T1D). In addition, the company is also engaged in the research and development of other candidates in its pipeline through collaborations with academic partners and license agreements, which include TTP273, HPP737, TTP-RA, Mavodelpar (HPP593), HPP971, and HPP3033, being studied and developed to counter various chronic diseases.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 26 |
| Exchange | NASDAQ |
| Company Website |
View the latest dividend and stock split events for vTv Therapeutics Inc.
Dividend | |
|---|---|
| Ex-Dividend Date | -- |
| Payment Date | -- |
| Dividend Per Share | -- |
Stock Split | |
|---|---|
| Split Date | -- |
| Split Ratio | -- |
Eligible investors can buy real shares of vTv Therapeutics Inc. (VTVT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to VTVT, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between VTVT shares and USD.
VTVT Shares to USD
1.00 VTVT shares = 20.765 USD
Calculations are estimates based on the latest available price and are for reference only.